Research progress on biomarkers related to ACPA-negative rheumatoid arthritis / 中国基层医药
Chinese Journal of Primary Medicine and Pharmacy
;
(12): 1116-1120, 2023.
Artículo
en Chino
| WPRIM
| ID: wpr-991870
ABSTRACT
Rheumatoid arthritis (RA) is a group of heterogeneous autoimmune diseases with erosive arthritis as the main clinical feature. The pathogenesis of RA remains unclear. Autoantibodies can be detected in blood or synovial fluid in approximately 70% of patients with RA in the early stage of the disease. Anti-citrullinated protein antibody (ACPA) is the most commonly used autoantibody in the diagnosis of RA. However, ACPA is not a specific antibody for RA. The discovery and clinical application of serum ACPA-negative RA biomarkers is of positive significance for the early diagnosis and prognosis improvement of RA. This paper reviews the research progress of ACPA-negative RA biomarkers.
Texto completo:
Disponible
Índice:
WPRIM (Pacífico Occidental)
Idioma:
Chino
Revista:
Chinese Journal of Primary Medicine and Pharmacy
Año:
2023
Tipo del documento:
Artículo
Similares
MEDLINE
...
LILACS
LIS